Immunotherapy: Oswald’s Partner in the Fight
In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy for non-small cell lung cancer.
Source link
Enter your account data and we will send you a link to reset your password.
Here you'll find all collections you've created before.